Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma

New England Journal of Medicine

Volumn 331, Issue 2, 1994, Pages 74-80

  Offit, Kenneth ^a,b,e   Coco, Francesco lo ^f,h   Louie, Diane C ^c   Parsa, Nasser Z ^a   Leung, Denis ^d   Portlock, Carol ^b   ye, Bihui H ^f   Lista, Florigio ^f,i   Filippa, Daniel A ^c   Rosenbaum, Ayala ^g   Ladanyi, Marc ^e   Jhanwar, Suresh ^c,e   Dalla Favera, Riccardo ^f   Chaganti, R S K ^a,e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Departmentof Medicine   (United States)

^c The Department of Pathology   (United States)

^d Epidemiology and Biostatistics   (United States)

^e Department of Human Genetics   (United States)

^f Columbia University ^*  (United States)

^g Columbia University ^*  (United States)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ Centro Studi e Ricerche di Sanit e Veterinaria dell Esercito   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LACTATE DEHYDROGENASE;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; FEMALE; GENE REARRANGEMENT; GENETIC MARKER; HISTOLOGY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; SOUTHERN BLOTTING; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; BLOTTING, SOUTHERN; CONFIDENCE INTERVALS; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; HUMAN; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0028227464     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199407143310202     Document Type: Article

References (40)

1. Devesa SS, Fears T Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992; 52: Suppl: 5432s-5440s
2. Simon R, Durrleman S, Hoppe RT, The Non-Hodgkin Lymphoma Pathologic Classification Project: long-term follow-up of 1153 patients with non-Hodgkin lymphomas. Ann Intern Med 1988; 109: 939-945
3. Fisher RI, Gaynor ER, Dahlberg S, Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002-1006
4. Armitage JO Treatment of non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1023-1030
5. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994
6. Gulati SC, Shank B, Black P, Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 1988; 6: 1303-1313
7. McMaster ML, Greer JP, Wolff SN, Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma. Cancer 1991; 68: 233-241
8. Offit K, Chaganti RSK Chromosomal aberrations in non-Hodgkin's lymphoma: biologic and clinical correlations. Hematol Oncol Clin North Am 1991; 5: 853-869
9. McKeithan TW Molecular biology of non-Hodgkin's lymphomas. Semin Oncol 1990; 17: 30-42
10. Yunis JJ, Mayer MG, Arnesen MA, Aeppli DP, Oken MM, Frizzera G bcl-2 and Other genomic alterations in the prognosis of large-cell lymphoma. N Engl J Med 1989; 320: 1047-1054
11. Offit K, Koduru PRK, Hollis R, 18q21 Rearrangement in diffuse large cell lymphoma: incidence and clinical significance. Br J Haematol 1989; 72: 178-183
12. Offit K, Wong G, Filippa DA, Tao Y, Chaganti RSK Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 1991; 77: 1508-1515
13. Offit K, Jhanwar S, Ebrahim SAD, Filippa D, Clarkson BD, Chaganti RSK t(3;22)(q27;q11): A novel translocation associated with diffuse non-Hodgkin's lymphoma. Blood 1989; 74: 1876-1879
14. Bastard C, Tilly H, Lenormand B, Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma. Blood 1992; 79: 2527-2531
15. Ye BH, Rao PH, Chaganti RSK, Dalla-Favera R Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 1993; 53: 2732-2735
16. Baron BW, Nucifora G, McCabe N, Espinosa R III, Le Beau MM, McKeithan TW Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc Natl Acad Sci U S A 1993; 90: 5262-5266
17. Kerckaert J-P, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 1993; 5: 66-70
18. Ye BH, Lista F, Lo Coco F, Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993; 262: 747-750
19. Lo Coco F, Ye BH, Lista F, Rearrangements of the BCL6 gene in large cell non-Hodgkin's lymphoma. Blood 1994; 83: 1757-1759
20. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-2135
21. Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RSK Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer 1991; 3: 189-201
22. Danieu L, Wong G, Koziner B, Clarkson B Predictive model for prognosis in advanced diffuse histiocytic lymphoma. Cancer Res 1986; 46: 5372-5379
23. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860-1861
24. Kempin S, Cirrincone C, Myers I, Combined modality therapy of advanced nodular lymphomas (NL): the role of nonspecific immunotherapy (MBV) as an important determinant of response and survival. Proc Am Soc Clin Oncol 1983; 2: 56-56 abstract.
25. Carrato A, Koziner B, Wong G, Randomized comparison of CHOP vs Bleo-CHOP for the treatment of diffuse non-Hodgkin's lymphoma (NHL): a five year update. Proc Am Soc Clin Oncol 1987; 6: 198-198 abstract.
26. Lowenthal DA, Koziner B, Lee BJ, The NHL-7: alternating non-cross resistant combination chemotherapy (CT) containing methyl-GAG (MG) for diffuse (D) non-Hodgkin's lymphoma (NHL). Proc Am Soc Clin Oncol 1987; 6: 197-197 abstract.
27. Warrell RP Jr, Straus DJ, Martin M, Short-term intensive treatment of intermediate-grade non-Hodgkin's lymphoma using infusional chemotherapy. Proc Am Soc Clin Oncol 1989; 8: 270-270 abstract.
28. Straus DJ, Wong GY, Liu J, Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. Am J Med 1991; 90: 328-337
29. O'Brien J, O'Keefe P, Roistacher N, NHL-15 protocol for diffuse aggressive lymphomas: a dose intense regimen of doxorubicin (D), vincristine (V), and cyclophosphamide (C). Blood 1992; 80: Suppl: 157a-157a abstract.
30. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
31. Cox DR Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187-220
32. Mitelman F. Catalog of chromosome aberrations in cancer. 4th ed. New York: Wiley-Liss, 1991.
33. Leroux D, Stul M, Sotto JJ, Translocation t(3;22)(q23;q11) in three patients with diffuse large B cell lymphoma. Leukemia 1990; 4: 373-376
34. Raghoebier S, Kramer MHH, van Krieken JHJM, Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma. Blood 1991; 78: 2680-2685
35. Clark HM, Jones DB, Wright DH Cytogenetic and molecular studies of t(14;18) and t(14;19) in nodal and extranodal B-cell lymphoma. J Pathol 1992; 166: 129-137
36. van Krieken JHJM, Raffeld M, Raghoebier S, Jaffe ES, van Ommen GJB, Kluin PM Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. Blood 1990; 76: 797-800
37. Rudders RA, Ross ME, DeLellis RA Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer 1978; 42: 406-416
38. Coiffier B, Gisselbrecht C, Vose JM, Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. J Clin Oncol 1991; 9: 211-219
39. Bastard C, Deweindt C, Kerckaert JP, LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 1994; 83: 2423-2427
40. Gribben JG, Neuberg D, Freedman AS, Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449-3457